NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Miguel Ángel Esteve
Miguel Ángel Esteve
Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
- Filter by:
- All
- LNP
- Polymers
- Analytics
- Regulatory
.png)
Over the past 20 years, polymer-based drug delivery systems have evolved from experimental platforms to clinically...
.jpg)
Messenger RNA (mRNA) technology surged into the global spotlight during the COVID-19 pandemic, showcasing its power to...
Early-stage research frequently takes center stage in the fields of biopharmaceuticals and the development of advanced...
Nanoparticle-based drug delivery has revolutionized how therapeutics can be transported and released within the human...
Process Performance Qualification (PPQ) is a critical part of the pharmaceutical manufacturing validation lifecycle,...
Currently, lipid nanoparticles (LNPs) stand as the predominant delivery system for emerging mRNA-based therapeutic...
RNA‑based therapeutics have rapidly evolved from niche research tools to transformative medicines, powering...
Peptide therapeutics offer high specificity and strong safety profiles, but their effectiveness depends on overcoming...